DL-Syringaresinol|cas 1177-14-6|Supplied by DC Chem

Cas No.:	1177-14-6
SMILES:	OC1=C(OC)C=C([C@H]2OC[C@@]3([H])[C@]2([H])CO[C@@H]3C4=CC(OC)=C(O)C(OC)=C4)C=C1OC
Formula:	C₂₂H₂₆O₈
M.Wt:	418.437
Purity:	>98%, Standard References Grade
Sotrage:	4°C for 1 year, -20°C for more than 2 years

Description:

For the detailed information of DL-Syringaresinol, the solubility of DL-Syringaresinol in water, the solubility of DL-Syringaresinol in DMSO, the solubility of DL-Syringaresinol in PBS buffer, the animal experiment（test） (test) of DL-Syringaresinol, the cell expriment (test) of DL-Syringaresinol, the in vivo, in vitro and clinical trial test of DL-Syringaresinol, the EC50, IC50,and Affinity of DL-Syringaresinol,, please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DCC-003	Vincristine	>98%,Standard References
DCZ-289	songorine	purity >98%,Standard References
DCZ-286	8-GERANOPSORALEN	purity >98%,Standard References
DCZ-290	Isobavachin	purity >98%,Standard References
DCZ-292	TECTOCHRYSIN	purity >98%,Standard References
DCZ-291	isorhapontigenin	purity >98%,Standard References
DCZ-287	Protopine	purity >98%,Standard References
DC8874	7-TACA	Impurity D of Cefoperazone
DCQ-033	fraxin	Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity.
DC23085	Dihydrocapsaicin	Dihydrocapsaicin, a potential inducer of autophagy, has cytotoxic activity. It has anti-atherogenic activity, can reduce the susceptibility of low-density lipoprotein (LDL) to oxidation. Dihydrocapsaicin treatment depletes peptidergic nerve fibers of subs